Is PHR or SOPH more undervalued in 2026?

CirclFi compares Phreesia, Inc. (PHR) and SOPHiA GENETICS SA (SOPH) using 13 institutional-grade valuation models. PHR has a Quality of Company score of 7.6/10 while SOPH scores 5.7/10.

Which is a better buy — PHR or SOPH?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do PHR and SOPH valuations compare?

PHR at $9.45 and SOPH at $5.08 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

PHR vs SOPH Valuation Comparison 2026 — Intrinsic Value Analysis

PHR

Health Information Services

Phreesia, Inc.

Quality

7.6

out of 10

Value Trap

LOW

Price

$9.45

Last close

Models

12/13

Active

SOPH

Health Information Services

SOPHiA GENETICS SA

Quality

5.7

out of 10

Value Trap

SAFE

Price

$5.08

Last close

Models

10/13

Active

Model-by-Model Comparison

Model	Type	PHR Fair Value	PHR Upside	SOPH Fair Value	SOPH Upside
Bayesian DCF	Intrinsic	$0.45	-95.3%	$1.31	-74.3%
Earnings Power Value	Intrinsic	$2.63	-72.2%	$2.53	-52.5%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for PHR vs SOPH — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

PHR vs SOPH — Which Stock Is More Undervalued?

PHR scores higher with a 7.6/10 quality rating vs SOPH's 5.7/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Phreesia, Inc. (PHR) and SOPHiA GENETICS SA (SOPH) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

PHR currently trades at $9.45 with a QOC of 7.6/10, while SOPH trades at $5.08 with a QOC of 5.7/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).